22 results on '"Kim, S.T."'
Search Results
2. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
3. Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients.
4. Estrogen receptor gene polymorphism and craniofacial morphology in female TMJ osteoarthritis patients.
5. Integral Imaging Based 3-D Image Encryption Algorithm Combined with Cellular Automata
6. Application of Taguchi Method for Optimization of Vacuum Plasma Sprayed CoNiCrAlY Coatings
7. Centrifugal Casting Practice and Microstructure and Mechanical Properties of a 2205 Duplex Stainless Steel
8. Short pulse generation in the mode-locked fibre laser using cholesteric liquid crystal
9. Endurable water-repellent glass for automobiles
10. Electrical properties of PZT thin films deposited by electron cyclotron resonance plasma enhanced chemical vapor deposition
11. P1.01-97 Modified RANO-LM Criteria to Evaluate the Radiological Response of Osimertinib in EGFR T790M Positive NSCLC with Leptomeningeal Metastases
12. 491 Cellular response patterns to single MEK inhibition correlate with the efficacy of combined MEK/CDK4,6 targeting in melanoma
13. 541 ERBB3 promoter polymorphisms and mRNA expression associated with lung cancer risk in Korean lung cancer patients.
14. 9143 Health-related quality of life (HRQOL) with sunitinib (SU) as maintenance therapy following carboplatin (C) and paclitaxel (P) treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC).
15. 3002 Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (mRCC).
16. 4517 POSTER Sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC).
17. 4514 POSTER Economic evaluation of sunitinib vs. interferon-alfa (IFN-a)in first-line metastatic renal cell carcinoma (mRCC).
18. 4513 POSTER Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC).
19. 4509 POSTER Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors.
20. 1108 POSTER Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib versus interferon (IFN)-alfa: results for European and US subsample analyses in a ...
21. Green electroluminescent characteristics of poly (2-dimethyloctylsilyl-1,4-phenylenevinylene)
22. Green electroluminescent characteristics of poly(2-dimethyloctylsilyl- 1,4-phenylenevinylene)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.